Literature DB >> 27260846

Management of disappearing colorectal liver metastases.

K Kuhlmann1, J van Hilst2, S Fisher3, G Poston3.   

Abstract

The development of new potent systemic treatment modalities has led to a significant increase in survival of patients with colorectal liver metastases. In the neo-adjuvant setting, these modalities can be used for patient selection, down staging, and conversion from non-resectable to resectable liver metastases. In addition, complete radiological disappearance of metastases can occur, the phenomenon of disappearing liver metastases. Because only a small percentage of these patients (0-8%) have a complete radiological response of all liver metastases, most patients will undergo surgery. At laparotomy, local residual disease at the site of the disappeared metastasis is still found in 11-67%, which highlights the influence of the imaging modalities used at (re)staging. When the region of the disappeared liver metastasis was resected, microscopically residual disease was found in up to 80% of the specimens. Alternatively, conservative management of radiologically disappeared liver metastases resulted in 19-74% local recurrence, mostly within two years. Obviously, these studies are highly dependent on the quality of the imaging modalities utilised. Most studies employed CT as the modality of choice, while MRI and PET was only used in selective series. Overall, the phenomenon of disappearing liver metastases seems to be a radiological rather than an actual biological occurrence, because the rates of macroscopic and microscopic residual disease are high as well as the local recurrence rates. Therefore, the disappeared metastases still require an aggressive surgical approach and standard (re)staging imaging modalities should include at least CT and MRI.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Disappearing liver metastases; Liver imaging; Pathological response; Radiological response; Systemic therapy

Mesh:

Year:  2016        PMID: 27260846     DOI: 10.1016/j.ejso.2016.05.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

Review 1.  Oligometastatic Disease in Colorectal Cancer - How to Proceed?

Authors:  Felix Aigner; Johann Pratschke; Moritz Schmelzle
Journal:  Visc Med       Date:  2017-02-03

2.  A radiological footprint equivalent to liquefactive necrosis observed in the course of disappearing liver metastases in rectal cancer: A case report and review of the literature.

Authors:  Kazuki Yamada; Yasuhiko Fujita; Teruyoshi Amagai
Journal:  Radiol Case Rep       Date:  2022-05-05

Review 3.  [Computed tomography and/or magnetic resonance imaging of the liver : How, why, what for?]

Authors:  G H Pöhler; K I Ringe
Journal:  Radiologe       Date:  2019-09       Impact factor: 0.635

4.  Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases.

Authors:  V Kepenekian; A Muller; P J Valette; P Rousset; M Chauvenet; G Phelip; T Walter; M Adham; O Glehen; G Passot
Journal:  BJS Open       Date:  2019-02-22

5.  Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review.

Authors:  Darius Barimani; Joonas H Kauppila; Christian Sturesson; Ernesto Sparrelid
Journal:  World J Surg Oncol       Date:  2020-10-08       Impact factor: 2.754

6.  What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?

Authors:  Qichen Chen; Xingchen Li; Jianjun Zhao; Xinyu Bi; Zhiyu Li; Zhen Huang; Yefan Zhang; Jianguo Zhou; Hong Zhao; Jianqiang Cai
Journal:  Ann Transl Med       Date:  2021-01

Review 7.  Current Surgical Management Strategies for Colorectal Cancer Liver Metastases.

Authors:  Gabriel D Ivey; Fabian M Johnston; Nilofer S Azad; Eric S Christenson; Kelly J Lafaro; Christopher R Shubert
Journal:  Cancers (Basel)       Date:  2022-02-20       Impact factor: 6.639

8.  The Influence of Radiological "Disappearing Lesions" on the Efficacy and Prognosis of Patients with Colorectal Liver Metastases Undergoing Conversion Therapy.

Authors:  Zhi-Yang Song; Dong Yang; Yang Liu; Yong Cheng
Journal:  Gastroenterol Res Pract       Date:  2022-02-22       Impact factor: 2.260

9.  Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.

Authors:  Francesco De Cobelli; Marco Calandri; Angelo Della Corte; Roberta Sirovich; Carlo Gazzera; Paolo Della Vigna; Guido Bonomo; Gianluca Maria Varano; Daniele Maiettini; Giovanni Mauri; Nicola Camisassi; Stephanie Steidler; Francesca Ratti; Simone Gusmini; Monica Ronzoni; Luca Aldrighetti; Bruno C Odisio; Patrizia Racca; Paolo Fonio; Andrea Veltri; Franco Orsi
Journal:  Eur Radiol       Date:  2022-01-29       Impact factor: 7.034

10.  The dilemma of the disappeared colorectal liver metastasis: systematic review of reviews and evidence gap map.

Authors:  Ahmed Nassar; Sorin Cimpean; Amir Abdelhamid; Robert P Jones; Roger Wahba; Guido Fiorentini; Luca Aldrighetti; Catherine Teh; Ruslan Alikhanov; John Hammond; Michael Silva; Areeg Abdelmabod; Stephanie Truant; Alessandro Ferrero; Christian Sturesson; Irfan Ahmed; Mudassar Ghazanfar; Nobuyuki Takemura; Timothy M Pawlik; Mohamed Bekheit
Journal:  BJS Open       Date:  2022-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.